Bilcare receives National Intellectual Property Award 2014 by DIPP

Bilcare Research's anti-counterfeit nonClonableID technology was approved for a crucial national project by the Council of Scientific and Industrial Research (CSIR) under its prestigious New Millennium Indian Technology Leadership Initiative (MITLI)Program

anti-counterfeiting-medicines

The technology has helped in product securitization for the global pharmaceuticals industry.

Bilcare Research has been awarded the National Intellectual Property Award 2014 by Government of India. This award is conferred to recognize and reward innovators of IP who have contributed to harnessing the country's intellectual capital and creating an eco-system that boots creativity and innovation.

Dr Praful R Naik, executive rirector, Bilcare was felicitated by Mr Amitabh Kant, secretary, Department of Industrial Policy and Promotion (DIPP) at a function held on 26 April 2014, the World Intellectual Property Day, jointly organized by CII and the Government of India.

While receiving the award, Dr Naik said: "Bilcare continual investment in innovation pathway and R&D has lead to creation of portfolio of novel products, processes and services as well as path breaking technologies, like nonClonableID (nCiD) technology which not only finds its place in product securitization for global pharmaceuticals but also application in e- governance initiatives in myriad government and non government sectors."

Bilcare has contributed to harness the country's intellectual capital and created an eco-system that's boosts creativity and innovation. The strong research orientation to Customer centric Innovations, Research and Development, has resulted in continual creation of valuable Intellectual Property in the form of Novel products and services and the path-breaking technology solution-nonClonableID technology (over 200 patent applications and 36 granted patents world-wide) resulting in global leadership with over 1000 pharmaceutical companies as well other industrial sectors.

Bilcarenon ClonableID (nCiD)technology was approved for a crucial national project by the Council of Scientific and Industrial Research under its prestigious New Millennium Indian Technology leadership Initiative Program entitled "Customized Adaptation of nonClonableID Technology to Establish Authenticity of Medical Products and Facilitate Improving Medication Compliance by Patients". 

Intellectual Property Office, Govt. of India under the Department of Industrial Policy and Promotion of Ministry of Commerce and Industry, Government of India selects the organizations and individuals for their outstanding contribution to Intellectual Property in the country, every year.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X